Exploring Emerging Therapies in Vitiligo

Opinion
Video

The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are transforming vitiligo management, with treatment selection guided by disease patterns, progression rates and individual patient response, while acknowledging the need for systematic assessment and alternative strategies for treatment-resistant cases.

Video content above is prompted by the following:

  • What are the most promising new vitiligo treatments?
  • How has this knowledge shaped current treatment approaches and new therapies?
  • How do vitiligo progression patterns affect treatment decisions and long-term management?
  • Describe your process to assess and manage treatment-resistant disease.
  • What is the role of newer targeted therapies in such cases?
Recent Videos
1 Kol is featured in this series
1 Kol is featured in this series
1 Kol is featured in this series
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 Kol is featured in this series
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.